Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC).
Cancer Chemother Pharmacol
; 80(6): 1147-1159, 2017 Dec.
Article
in En
| MEDLINE
| ID: mdl-29043411
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Receptor, ErbB-2
/
Trastuzumab
/
Maytansine
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
Germany